Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: A prospective randomized comparative study

BJU International

Volumn 111, Issue 1, 2013, Pages 129-136

  Akman, Tolga ^a   Binbay, Murat ^b   Tekinarslan, Erdem ^b   Tepeler, Abdulkadir ^a   Akcay, Muzaffer ^a   Ozgor, Faruk ^b   Ugurlu, Mesut ^b   Muslumanoglu, Ahmet ^b  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

bipolar; erectile dysfunction; monopolar; transurethral resection of prostate; TURP

Indexed keywords

SODIUM;

ADULT; ARTICLE; BIPOLAR TRANSURETHRAL RESECTION; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOPOLAR TRANSURETHRAL RESECTION; OPERATION DURATION; PENIS ERECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTVOID RESIDUAL URINE VOLUME; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SCORING SYSTEM; SODIUM BLOOD LEVEL; TRANSURETHRAL RESECTION; URINARY TRACT FUNCTION; URINE FLOW RATE;

EID: 84871606663     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11266.x     Document Type: Article

References (21)

1. Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW,. A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 2007; 52: 517-522
2. Michielsen DP, Debacker T, De Boe V, et al. Bipolar transurethral resection in saline-an alternative surgical treatment for bladder outlet obstruction? J Urol 2007; 178: 2035-2039
3. Starkman JS, Santucci RA,. Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int 2005; 95: 69-71
4. Chen Q, Zhang L, Fan QL, Zhou J, Peng YB, Wang Z,. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int 2010; 106: 1339-1343
5. Fagerström T, Nyman CR, Hahn RG,. Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. BJU Int 2010; 105: 1560-1564
6. Fagerström T, Nyman CR, Hahn RG,. Complications and clinical outcome 18 months after bipolar and monopolar transurethral resection of the prostate. J Endourol 2011; 25: 1043-1049
7. Seckiner I, Yesilli C, Akduman B, et al. A prospective randomized study for comparing bipolar plasmakinetic resection of the prostate with standard TURP. Urol Int 2006; 76: 139-143
8. Iori F, Franco G, Leonardo C, et al. Bipolar transurethral resection of prostate: clinical and urodynamic evaluation. Urology 2008; 71: 252-255
9. Tefekli A, Muslumanoglu AY, Baykal M, Binbay M, Tas A, Altunrende F,. A hybrid technique using bipolar energy in transurethral prostate surgery: a prospective, randomized comparison. J Urol 2005; 174: 1339-1343
10. Mamoulakis C, Skolarikos A, Schulze M, et al. Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int 2012; 109: 240-248
11. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637-649
12. Boyle P, Robertson C, Mazzetta C, et al. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int 2003; 92: 719-725
13. Kaplan SA, Gonzalez RR, Te AE,. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Eur Urol 2007; 51: 1717-1723
14. Faydaci G, Kuyumcuoglu U, Eryildirim B, Aktas A, Tarhan F, Tuncer M,. Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms. Int Urol Nephrol 2011; 43: 619-624
15. Egerdie RB, Auerbach S, Roehrborn CG, et al. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study. J Sex Med 2012; 9: 271-281
16. Roehrborn CG, Kaminetsky JC, Auerbach SM, Montelongo RM, Elion-Mboussa A, Viktrup L., Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment. BJU Int 2010; 105: 502-507
17. Walsh PC, Lepor H, Eggleston JC, et al. Radical pros-tatectomy with preservation of sexual function: anatomi-cal and pathological considerations. Prostate 1983; 4: 473-485
18. Mishriki SF, Grimsley SJ, Lam T, Nabi G, Cohen NP,. TURP and sex: patient and partner prospective 12 years follow-up study. BJU Int 2011; 109: 745-750
19. Deliveliotis C, Liakouras C, Delis A, Skolarikos A, Varkarakis J, Protogerou V,. Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population. Urol Res 2004; 32: 283-289
20. Bieri S, Iselin CE, Rohner S,. Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997; 31: 545-548
21. Poulakis V, Ferakis N, Witzsch U, de, Vries R, Becht E., Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients. Asian J Androl 2006; 8: 69-74